Kairos Pharma announces 1-for-7 reverse stock split effective Sept. 1, 2026 - KAPA News | RalliesKairos Pharma announces 1-for-7 reverse stock split effective Sept. 1, 2026
K
KAPA• Reverse stock split details
- Kairos Pharma will execute a 1-for-7 reverse stock split, effective Sept. 1, 2026 at 12:01 a.m. ET.
- Shares will trade split-adjusted at the Sept. 1 market open on NYSE American under KAPA.
- The outstanding share count will fall, aiming to lift the per-share price to support NYSE American listing compliance.
- Convertible notes, warrants, and equity awards will be proportionately adjusted to reflect the 1-for-7 ratio.
- Authorized share counts, par value, and ownership percentages remain essentially unchanged, excluding minor rounding effects from fractional shares.
•
